Zacks Investment Research on MSN1d
FDA Approves Novartis Drug for Rare Kidney Disease Treatment
Novartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved ...
Alnylam Pharma Stock (ALNY) Rockets on FDA Drug Approval
Alnylam Pharma (ALNY) stock rocketed higher on Friday after the pharmaceutical company received approval from the U.S. Food and Drug ...
Telix Pharmaceuticals Gets FDA Approval for Prostate Cancer Screening Agent
Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...
A world of pain: How a ‘safe’ painkiller unleashed a new wave of opioid addiction
Rob Poole, a psychiatrist who ran a clinic in Wales to help patients come off opioids, said many pain doctors are ...
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...
Fierce Pharma2d
J&J advances Stelara succession scheme with FDA nod for Tremfya in Crohn's disease
With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...
US FDA Expands Approval for Alnylam's Drug to Treat Rare Heart Disease
(Reuters) -U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, ...
BizPac Review4d
Stephen Moore: The FDA can save lives by keeping copycat drugs off the market
The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold ...
Some Philly patients worry about affording their medications as insurers cut coverage for weight-loss drugs
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
Generation Xanax: The Dark Side of America’s Wonder Drug
Amid rising concerns about benzodiazepines, some patients who try to quit are suffering extreme anxiety, memory loss and ...
Multiple Sclerosis News Today9d
FDA approves prefilled syringe formulation of Ani’s Cortrophin Gel
The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...
The Cardiology Advisor10d
FDA Drug Approval Decisions Expected in April 2025
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.